MD2188F1 - Metoda de tratament al epilepsiei - Google Patents

Metoda de tratament al epilepsiei Download PDF

Info

Publication number
MD2188F1
MD2188F1 MD20030064A MD20030064A MD2188F1 MD 2188 F1 MD2188 F1 MD 2188F1 MD 20030064 A MD20030064 A MD 20030064A MD 20030064 A MD20030064 A MD 20030064A MD 2188 F1 MD2188 F1 MD 2188F1
Authority
MD
Moldova
Prior art keywords
epilepsy treatment
treatment
lydase
antiepileptic
neurology
Prior art date
Application number
MD20030064A
Other languages
English (en)
Other versions
MD2188G2 (ro
Inventor
Oleg Cobaleanschi
Original Assignee
Oleg Cobaleanschi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oleg Cobaleanschi filed Critical Oleg Cobaleanschi
Priority to MDA20030064A priority Critical patent/MD2188G2/ro
Publication of MD2188F1 publication Critical patent/MD2188F1/ro
Publication of MD2188G2 publication Critical patent/MD2188G2/ro

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MDA20030064A 2003-02-28 2003-02-28 Metodă de tratament al epilepsiei MD2188G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20030064A MD2188G2 (ro) 2003-02-28 2003-02-28 Metodă de tratament al epilepsiei

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20030064A MD2188G2 (ro) 2003-02-28 2003-02-28 Metodă de tratament al epilepsiei

Publications (2)

Publication Number Publication Date
MD2188F1 true MD2188F1 (ro) 2003-06-30
MD2188G2 MD2188G2 (ro) 2003-12-31

Family

ID=19740095

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20030064A MD2188G2 (ro) 2003-02-28 2003-02-28 Metodă de tratament al epilepsiei

Country Status (1)

Country Link
MD (1) MD2188G2 (ro)

Also Published As

Publication number Publication date
MD2188G2 (ro) 2003-12-31

Similar Documents

Publication Publication Date Title
IL225192A (en) Combinations of dextromethorphan and quinidine for the preparation of mental illness, neuropathic pain or brain injury
AU2018240515A1 (en) Nucleic acids encoding CRISPR-associated proteins and uses thereof
IL171607A (en) Use of botulinum toxin for the treatment of sinusitis-induced headaches
WO2005034843A3 (en) Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
EA201590654A1 (ru) Комбинация разагилина и придопидина для лечения нейродегенеративных нарушений, в частности болезни хантингтона
HK1202776A1 (en) Use of laquinimod for treating crohn's disease patients who failed first-line anti-tnf therapy
WO2006014159A3 (en) Methods of using regenerative cells in the treatment of musculoskeletal disorders
WO2003092617A3 (en) Combinations for the treatment of inflammatory skin disorders
EA201890182A1 (ru) Терапевтическое средство для лечения синдрома гунтера и способ его лечения
PH12021553102A1 (en) Methods of treating fabry disease in patients having renal impairment
TW200630089A (en) Treatment methods
WO2006022612A3 (en) Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
WO2003057162A3 (en) Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases
MX2019008076A (es) Regimen terapeutico para el tratamiento de fabry usando alfa-galactosidasa estabilizada.
DE60222383D1 (de) Medikament zur verabreichung von amifostin und verwandten wirkstoffen
ZA202002107B (en) Use of specific sirna against protein s for the treatment of hemophilia
MX2025000682A (es) Composicion farmaceutica de anticuerpo anti-cd20 y uso de la misma
MD2188F1 (ro) Metoda de tratament al epilepsiei
EP4327869A3 (en) Methods of treating fabry patients having renal impairment
BRPI0412506A (pt) células autólogas que induzem à autotoleráncia de origem monocìtica e seu uso em preparações farmacêuticos
TW200501958A (en) A therapeutic agent for treating a behavioral disorder
JOP20200046A1 (ar) طرق لعلاج أمراض مرتبطة بـtnf?
WO2018136647A3 (en) Therapeutic use of beta-lactams in hematopoiesis, immuno-oncology therapy, and regulation of lipoprotein and apolipoprotein levels
RU2002113429A (ru) Способ лечения псориаза
Suter-Montano Molgramostim/peginterferon-α-2a

Legal Events

Date Code Title Description
MM4A Patent for invention definitely lapsed due to non-payment of fees